AGA Medical Holdings Inc. (NASDAQ: AGAM) filed a lawsuit against W.L. Gore & Associates alleging that the Newark, Del.-based company is infringing on a patent for its transcatheter occlusion device for heart defect treatment.
In a lawsuit filed in the U.S. District Court for Minnesota, AGA Medical alleges that Gore’s Helex Septal Occluder device employs technology covered by five claims in its patent for “Percutaneous Catheter Directed Constructing Occlusion Device.”
The Plymouth, Minnesota-based cardiac and vascular device maker said it wants a jury to decide whether Gore‘s device infringes the patent, a permanent injunction barring further infringement and damages.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In June, a German court awarded AGA Medical €2.1 million, or roughly $2.6 million, in a patent infringement spat with Occlutech GmbH over intravascular occlusion devices and the method of manufacturing those devices.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
